`
`Inventors: GEUIJEN el al.
`
`Confirmation No.: 5717
`
`Applicant: MERUS NV.
`
`Art Unit: 1643
`
`Application No.: 15/121,623
`
`Examiner: Rawlings, Stephen L.
`
`371(c) Date: August 25, 2016
`
`Atty. Docket: 4096.0100002/DAS/PAC
`
`Title: ANTIBODY THAT BINDS ERBB-Z AND ERBB-3
`
`Statement of Substance of Interview
`
`In Accordance With 37 C.F.R. § 1.133(b) and M.P.E.P. § 713.04
`
`Commissioner for Patents
`
`PO Box 1450
`
`Alexandria, VA 22313-1450
`
`Commissioner:
`
`In reply to the Interview Summary (Form PTOL-413) mailed by the US. Patent &
`
`Trademark Office on May 16, 2018, Applicant submits herewith the following Statement of
`
`Substance of the Interview held with Examiner Stephen Rawlings, on May 11 2018, regarding
`
`the above captioned application in accordance with 37 C.F.R. § 1.133(b) and M.P.E.P. § 713.04.
`
`A summary of the interview follows:
`
`During the interview, claims 1-4, 6-13, 18-22, 28, 30-33, 35, and 58-71 were discussed,
`
`along with the grounds of rejection set forth in the Office Action mailed November 27, 2017 in
`
`light of the Amendment filed April 27, 2018.
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & Fox P.L.L.C.
`
`/Paul A. Calvo, Reg. No. 57913/
`
`Paul A. Calvo
`
`Attorney for Applicant
`Registration No. 57,913
`
`9449248_1.d0cx
`
`Date:
`
`6.14.2018
`
`1100 New York Avenue, NW.
`Washington, DC. 20005-3934
`(202) 371-2600
`
`